A front-page article in the Philadelphia Inquirer explores the promise of Penn Medicine's new Center Personalized Diagnostics, a joint initiative of the department of Pathology and Laboratory Medicine and the Abramson Cancer Center. David Roth, MD, PhD , chair of the department of Pathology and Laboratory Medicine, and Lynn Schuchter, MD , chief of the division of Hematology-Oncology, are quoted in the story, and Robert Daber, PhD, Technical Director of Clinical Genomics in the Center for Personalized Diagnostics appears in a photo accompanying the article. About 375 cancer patients have gotten the tests since February, and Roth's team is focusing on clinically "actionable" results. That means results that help doctors choose a treatment or trial or rule out a treatment, such as a bone marrow transplant, that is unlikely to help. "We are practical people," Roth said. "This is not meant to be primarily a research enterprise."
Read the entire Philadelphia Inquirer article